Coagulation and fibrosis: A potential non-negligible target of statins in chronic hepatitis

J Hepatol. 2015 Jul;63(1):277-8. doi: 10.1016/j.jhep.2015.02.027. Epub 2015 Feb 26.

Authors

Niccolò Bitto¹, Francesco Salerno¹, Armando Tripodi², Vincenzo La Mura³

Affiliations

¹ Unit of Internal Medicine, IRCCS San Donato, San Donato Milanese (MI), University of Milan, Italy.
² Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Clinical Sciences and Community Health, University of Milan and IRCCS Ca' Granda Maggiore Hospital Foundation, Milan, Italy.
³ Unit of Internal Medicine, IRCCS San Donato, San Donato Milanese (MI), University of Milan, Italy. Electronic address: vin.lamura@gmail.com.

PMID: 25725439
DOI: 10.1016/j.jhep.2015.02.027

No abstract available

Publication types

Letter
Comment

MeSH terms

Female
Hepatitis C, Chronic / drug therapy*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Liver / pathology*
Liver Cirrhosis / prevention & control*
Male

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors